Red cell fragmentation (schistocytosis) after bone marrow transplantation

Bone Marrow Transplantation

Volumn 22, Issue 8, 1998, Pages 777-780

  Zomas, A ^a,b   Saso, R ^a   Powles, R ^a   Mackay, H ^a   Singhal, S ^a,c   Treleaven, J ^a   Mehta, J ^c  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

^b St Anargyri General Cancer Hospital   (Greece)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Hemolytic uremic syndrome; Hone marrow transplantation; Microangiopathic hemolytic anemia; Schistocytosis; Thrombotic microangiopathy; Thrombotic thrombocytopenic purpura

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; MELPHALAN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; AUTOGRAFT; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BONE MARROW TRANSPLANTATION; CELL DAMAGE; CELL STRUCTURE; CHILD; CHRONIC MYELOID LEUKEMIA; DISEASE SEVERITY; ERYTHROCYTE; FLUID BALANCE; HEMOLYSIS; HEMOLYTIC UREMIC SYNDROME; HUMAN; LEUKEMIA; MAJOR CLINICAL STUDY; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHISTOCYTOSIS; SCHOOL CHILD; THROMBOTIC THROMBOCYTOPENIC PURPURA; WHOLE BODY RADIATION;

EID: 0031794818     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701442     Document Type: Article

References (21)

1. Pettitt AR, Clark RE. Thrombotic microangiopathy following bone marrow transplantation. Bone Marrow Transplant 1994; 14: 495-504.
2. Marshall RJ, Sweny P. Haemolytic-uraemic syndrome in recipients of bone marrow transplants not treated with cyclosporin A. Histopathol 1986; 10: 953-962.
3. Chappell ME, Keeling DM, Prentice HG, Sweny P. Haemolytic uraemic syndrome after bone marrow transplantation: an adverse effect of total body irradiation? Bone Marrow Transplant 1988; 3: 339-347.
4. Holler E, Kolb HJ, Killer E et al. Microangiopathy in patients on cyclosporine prophylaxis who developed acute graft-versus-host disease after HLA-identical bone marrow transplantation. Blood 1989; 73: 2018-2024.
5. Cohen H, Bull HA, Seddon A et al. Vascular endothelial cell function and ultrastructure in thrombotic microangiopathy following allogeneic bone marrow transplantation. Eur J Haematol 1989; 43: 207-214.
6. Loomis LJ, Aronson AJ, Rudinsky R, Spargo BH. Hemolytic uremic syndrome following bone marrow transplantation: a case report and review of the literature. Am J Kidney Dis 1989; 14: 324-328.
7. Rabinowe SN, Soiffer RJ, Tarbell NJ et ai Hemqlytic-uremic syndrome following bone marrow transplantation in adults for hematologic malignancies. Blood 1991; 77: 1.837-1844.
8. Juckett M, Perry EH, Daniels BS, Weisdorf DJ. Mernolytic uremic syndrome following bone marrow transplantation. Bone Marrow Transplant 1991; 7: 405-409.
9. Carlson K, Smedmyr B, Hagberg H et al. Haemolytic uraemic syndrome and renal dysfunction following BEAC (BCNU, etoposide, ara-C, cyclophosphamide) ± TBI and autologous BMT for malignant lymphomas. Bone Marrow Transplant 1993; 11: 205-208.
10. Oursler DP, Holley KE, Wagoner RD. Hemolytic uremic syndrome after bone marrow transplantation without total body irradiation. Am J Nephrol 1993; 13: 167-170.
11. Zeigler ZR, Shadduck RK, Nemunaitis J et al. Bone marrow transplant-associated thrombotic microangiopathy: a case series. Bone Marrow Transplant 1995; 15: 247-253.
12. Gomez S, Nagler A, Naparstek E, Slavin S. Transient elevation of serum lactic dehydrogenase following autologous bone marrow transplantation. Bone Marrow Transplant 1991; 7: 487-188.
13. Sierra J, Conde E, Iriondo A et al. Frozen vs. nonfrozen bone marrow for autologous transplantation in lymphomas: a report from the Spanish GEL/TAMO Cooperative Group. Ann Hemalol 1993; 67: 111-114.
14. McDonald GB, Shulman HM, Sullivan KM, Spencer GD. Intestinal and hepatic complications of human bone marrow transplantation. Gastroenterol 1986; 90: 460-477, 770-784.
15. Mehta J, Powles R, Horton C et al. The relationship between donor-recipient blood group incompatibility and serum bilirubin after allogeneic bone marrow transplantation from HLA-identical siblings. Bone Marrow Transplant 1995; 15: 853-858.
16. Mehta J, Powles RL, Mitchell P et al. Graft failure after bone marrow transplantation from unrelated donors using busulphan and cyclophosphamide for conditioning. Bone Marrow Transplant 1994; 13: 583-587.
17. Powles R, Mehta J, Singhal S et al. Autologous bone marrow or peripheral blood stem cell transplantation followed by maintenance chemotherapy for adult acute lymphoblastic leukemia in first remission: 50 cases from a single center. Bone Marrow Transplant 1995; 16: 241-247.
18. Mehta J, Powles R, Singhai S et al. Autologous bone marrow transplantation for acute myeloid leukemia in first remission: identification of modifiable prognostic factors. Bone Marrow Transplant 1995; 16: 499-506.
19. Mehta J, Powles R, Horton C et al. Bone marrow transplantation for primary refractory acute leukaemia. Bone Marrow Transplant 1994; 14: 415-418.
20. Mehta J, Powles R, Singhal S et al. Transfusion requirements after bone marrow transplantation from HLA-identical siblings: effects of donor-recipient ABO incompatibility. Bone Marrow Transplant 1996; 18: 151-156.
21. Hamblin M, Powles R, Treleaven J et al. Defibrotide for refractory thrombotic thrombocytopenic purpura (TTP) after bone marrow transplantation. Blood 1996; 88 (Suppl. 1): 60b.